1. Availability and quality of data on pharmaceutical benefit financing components of health care system in United States, United Kingdom, Denmark, Germany, Italy and Poland.
- Author
-
Hermanowski, Tomasz, Szafraniec-Burylo, Sylwia I., Ceglowska, Urszula, Drozdowska, Aleksandra, Duleba, Dominika, Kowalczyk, Marta, Krancberg, Aleksandra N., Pashos, Chris L., Szczypior, Andrzej, Chmielewska, Malgorzata, and Czech, Marcin
- Subjects
PHARMACEUTICAL industry - Abstract
The abstract presents results of the "InterQuality Project - International Research Project on Financing Quality in Healthcare" funded by the 7th Framework Programme (FP7) for Research and Technological Development of the European Union. Grant Agreement No: HEALTH-F3-2010-261369 Objective: To assess reliability, validity and completeness of data on pharmaceutical benefit financing components of health care in United States, United Kingdom, Denmark, Germany, Italy and Poland Theory: Information and guidance used by authorities for decision making in the financing of pharmaceutical care should be reliable, valid and complete. Methods: A systematic review of literature published in the last 10 years, found electronically in Medline, Embase, the Cochrane Library and SCOPUS, supplemented by a manual search, was conducted. Quality of publications was critically appraised using PRISMA [1], MOOSE [2] and STROBE [3] checklists. Contents of found literature were assessed in terms of consistency, coherence and strength. Results: In total, 439 full text publications were included, of which 198 papers were assessed for quality. Of these, 24,6%, 31,2% and 22,1% publications presented high levels of: consistency, coherence and strength, respectively, and 4,3% presented concurrently high levels of all assessed areas. Several areas of weak data availability were identified. Discussion: No comparable analyses were found. Credible data were often unavailable. A questionnaire and a template helpful to collect data where more information is needed were developed, validated and will be sent to experts from InterQuality Consortium countries. Conclusion: To improve the quality of information available to decision makers, so that it is more credible, multiple sources should be used. [ABSTRACT FROM AUTHOR]
- Published
- 2013